Bevacizumab-Based Chemotherapy Combined with Regional Deep Capacitive Hyperthermia in Metastatic Cancer Patients: A Pilot Study

As an angiogenesis inhibitor, bevacizumab has been investigated in combination with different chemotherapeutic agents, achieving an established role for metastatic cancer treatment. However, potential synergic anti-angiogenic effects of hyperthermia have not tested to date in literature. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranieri, Girolamo, Ferrari, Cristina, Di Palo, Alessandra, Marech, Ilaria, Porcelli, Mariangela, Falagario, Gianmarco, Ritrovato, Fabiana, Ramunni, Luigi, Fanelli, Margherita, Rubini, Giuseppe, Gadaleta, Cosmo Damiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535949/
https://www.ncbi.nlm.nih.gov/pubmed/28684680
http://dx.doi.org/10.3390/ijms18071458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535949/
https://www.ncbi.nlm.nih.gov/pubmed/28684680
http://dx.doi.org/10.3390/ijms18071458

Ejemplares similares